NanHua Bio-medicine Co., Ltd (000504.SZ)
CNY 9.85
(0.82%)
CNY 9.85
(0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 136.79 Million | 200.34 Million | 156.61 Million | 175.56 Million | 134.16 Million | 95.38 Million |
| Cost of Revenue | 44.84 Million | 70.53 Million | 45.68 Million | 78.08 Million | 49.68 Million | 32.6 Million |
| Gross Profit | 91.94 Million | 129.8 Million | 110.93 Million | 97.48 Million | 84.47 Million | 62.77 Million |
| Operating Expenses | 137.65 Million | 117.6 Million | 106.93 Million | 73.04 Million | 89.6 Million | 75.84 Million |
| Selling, General and Administrative Expenses | 115.74 Million | 76.17 Million | 72.46 Million | 48.04 Million | 48.57 Million | 33.99 Million |
| Research and Development Expenses | 12.56 Million | 9.98 Million | 8.54 Million | 4.97 Million | 15.51 Million | 16.06 Million |
| Other Expenses | 9.35 Million | 31.44 Million | 25.92 Million | 20.03 Million | 25.52 Million | -1.18 Million |
| Cost and Expenses | 182.5 Million | 188.14 Million | 152.61 Million | 151.13 Million | 139.29 Million | 108.45 Million |
| Operating Income | -45.71 Million | 17.07 Million | 4.4 Million | 18.94 Million | 35.13 Million | -34.65 Million |
| Interest Expense | 11.07 Million | 11.86 Million | 14.11 Million | 4.01 Million | 8.87 Million | 10.65 Million |
| Income Tax Expense | 2.07 Million | 8.2 Million | 2.87 Million | 4.33 Million | -819.5 Thousand | 2.2 Million |
| Earnings before Tax | -44.7 Million | -21.55 Million | -30.22 Million | 18.96 Million | 17.44 Million | -35.84 Million |
| Net Income | -28.17 Million | -29.76 Million | -33.1 Million | 14.63 Million | 18.8 Million | -35.18 Million |
| Earnings Per Share Basic | -0.09 | -0.10 | -0.11 | 0.05 | 0.06 | -0.11 |
| Earnings Per Share Diluted | -0.09 | -0.10 | -0.11 | 0.05 | 0.06 | -0.11 |
| Weighted Average Shares Outstanding | 313.02 Million | 311.57 Million | 311.57 Million | 311.57 Million | 311.57 Million | 311.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 313.02 Million | 311.57 Million | 311.57 Million | 311.57 Million | 311.57 Million | 319.89 Million |
| Gross Margin | 0.67 | 0.65 | 0.71 | 0.56 | 0.63 | 0.66 |
| EBIT Margin | -0.13 | 0.12 | 0.07 | 0.16 | 0.30 | -0.09 |
| Profit Margin | -0.21 | -0.15 | -0.21 | 0.08 | 0.14 | -0.37 |
| EBITDA | -17.69 Million | 7.6 Million | 677.68 Thousand | 26.33 Million | 36.68 Million | -20.15 Million |
| Earnings Before Tax Margin | -0.33 | 0.09 | 0.03 | 0.11 | 0.26 | -0.36 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 36.09 Million | 30.35 Million | 25.97 Million | 32.03 Million | 136.79 Million | 34.32 Million |
| Cost of Revenue | 9.91 Million | 10.41 Million | 9.2 Million | 9.31 Million | 43.68 Million | 10.65 Million |
| Gross Profit | 26.17 Million | 19.93 Million | 16.76 Million | 22.71 Million | 93.1 Million | 23.67 Million |
| Operating Expenses | 22.4 Million | 22.06 Million | 20.13 Million | 31.56 Million | 102.15 Million | 23.93 Million |
| Selling, General and Administrative Expenses | 46.86 Million | 2.64 Million | 17.99 Million | -11.03 Million | - | 39.68 Million |
| Research and Development Expenses | 2.96 Million | 1.88 Million | 2.18 Million | 5.62 Million | - | 2.57 Million |
| Other Expenses | -27.42 Million | -4773.93 | -1819.75 | -37.82 | 1 Million | 4708.70 |
| Cost and Expenses | 32.32 Million | 32.48 Million | 29.34 Million | 40.87 Million | 145.84 Million | 34.58 Million |
| Operating Income | 3.6 Million | -8.58 Million | -2.47 Million | -50.57 Million | -45.71 Million | 11.27 Million |
| Interest Expense | 714.93 Thousand | - | 709.47 Thousand | 3.41 Million | 11.07 Million | 2.44 Million |
| Income Tax Expense | 847.21 Thousand | 194.38 Thousand | 368.96 Thousand | 909.37 Thousand | 2.07 Million | 744.97 Thousand |
| Earnings before Tax | 3.59 Million | -8.58 Million | -2.47 Million | -50.57 Million | -44.7 Million | 11.27 Million |
| Net Income | -17.92 Thousand | -5.62 Million | -2.77 Million | -28.65 Million | -28.17 Million | 9.45 Million |
| Earnings Per Share Basic | -0.00 | -0.02 | -0.01 | -0.08 | - | 0.03 |
| Earnings Per Share Diluted | -0.00 | -0.02 | -0.01 | -0.08 | - | 0.03 |
| Weighted Average Shares Outstanding | 329.83 Million | 329.83 Million | 329.83 Million | 339.51 Million | 313.02 Million | 311.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 329.83 Million | 329.83 Million | 329.83 Million | 339.51 Million | 313.02 Million | 311.57 Million |
| Gross Margin | 0.73 | 0.66 | 0.65 | 0.71 | 0.68 | 0.69 |
| EBIT Margin | 0.12 | -0.09 | -0.06 | -0.24 | - | 0.00 |
| Profit Margin | -0.00 | -0.19 | -0.11 | -0.89 | -0.21 | 0.28 |
| EBITDA | 4.3 Million | -2.77 Million | -1.67 Million | -7.57 Million | - | 32.28 Thousand |
| Earnings Before Tax Margin | 0.10 | -0.28 | -0.10 | -1.58 | -0.33 | 0.33 |
SG
RSF
BHPA
NEXOF
UANG
TKAYF